scispace - formally typeset
G

Geoffrey M. Silver

Researcher at Loyola University Chicago

Publications -  27
Citations -  1350

Geoffrey M. Silver is an academic researcher from Loyola University Chicago. The author has contributed to research in topics: Burn injury & Proteome. The author has an hindex of 21, co-authored 27 publications receiving 1308 citations. Previous affiliations of Geoffrey M. Silver include University of Vermont.

Papers
More filters
Journal ArticleDOI

Quantitative Proteome Analysis of Human Plasma following in Vivo Lipopolysaccharide Administration Using 16O/18O Labeling and the Accurate Mass and Time Tag Approach

TL;DR: An initial demonstration of proteome-wide quantitative analysis of human plasma using postdigestion trypsin-catalyzed 16O/18O peptide labeling, two-dimensional LC-FTICR mass spectrometry, and the accurate mass and time (AMT) tag strategy to identify and quantify peptides/proteins from complex samples is described.
Journal ArticleDOI

Toxic epidermal necrolysis: does immunoglobulin make a difference?

TL;DR: A multicenter, prospective, double-blinded randomized trial is necessary and urgently indicated to determine whether Ig therapy is beneficial or harmful in the care of TEN patients.
Journal ArticleDOI

High Dynamic Range Characterization of the Trauma Patient Plasma Proteome

TL;DR: This study established an extensive reference protein database for trauma patients that provides a foundation for future high throughput quantitative plasma proteomic studies designed to elucidate the mechanisms that underlie systemic inflammatory responses.
Journal ArticleDOI

Cell-specific expression and pathway analyses reveal alterations in trauma-related human T cell and monocyte pathways

Krzysztof Laudanski, +56 more
TL;DR: Genome-wide expression analysis of highly enriched circulating leukocyte subpopulations, combined with cell-specific pathway analyses, offers an opportunity to discover leukocytes regulatory networks in critically injured patients.
Journal ArticleDOI

Treatment of intra-abdominal infection with granulocyte colony-stimulating factor.

TL;DR: The use of a neutrophil growth factor, recombinant human granulocyte colony-stimulating factor (G-CSF), to improve survival in a well-established sepsis model, cecal ligation and puncture (CLP), resulted in a dose-dependent improvement in survival.